標(biāo)題: Titlebook: Bisphosphonates and Tumor Osteolysis; Kurt W. Brunner,Herbert Fleisch,Hans-J?rg Senn Conference proceedings 1989 Springer-Verlag Berlin He [打印本頁] 作者: bankrupt 時間: 2025-3-21 17:08
書目名稱Bisphosphonates and Tumor Osteolysis影響因子(影響力)
書目名稱Bisphosphonates and Tumor Osteolysis影響因子(影響力)學(xué)科排名
書目名稱Bisphosphonates and Tumor Osteolysis網(wǎng)絡(luò)公開度
書目名稱Bisphosphonates and Tumor Osteolysis網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Bisphosphonates and Tumor Osteolysis被引頻次
書目名稱Bisphosphonates and Tumor Osteolysis被引頻次學(xué)科排名
書目名稱Bisphosphonates and Tumor Osteolysis年度引用
書目名稱Bisphosphonates and Tumor Osteolysis年度引用學(xué)科排名
書目名稱Bisphosphonates and Tumor Osteolysis讀者反饋
書目名稱Bisphosphonates and Tumor Osteolysis讀者反饋學(xué)科排名
作者: wreathe 時間: 2025-3-21 23:33 作者: 歡樂東方 時間: 2025-3-22 01:03 作者: 外向者 時間: 2025-3-22 07:52
https://doi.org/10.1007/978-3-642-92439-2ey, breast, prostate, and ovary (Myers 1960). As therapeutic regimens in the treatment of malignant disorders have been improved in recent years, resulting in prolonged survival of patients, humoral hypercalcemia of malignancy has become a more frequent and often serious complication of tumor diseas作者: Apogee 時間: 2025-3-22 11:35 作者: Lasting 時間: 2025-3-22 16:39 作者: 敬禮 時間: 2025-3-22 20:16
,Die Hornochschen Aufgaben (134–155),f these patients suffer from osteolytic bone metastases at some time during the course of their disease (Elte et al. 1986). Hypercalcemia is a frequent complication in patients with extensive lesions in the skeleton. Osteolytic bone metastases cause severe morbidity and often incapacitate the patien作者: overbearing 時間: 2025-3-23 01:10
Effect of Long-Term Bisphosphonate Treatment on Morbidity Due To Bone Metastases in Breast Cancer Pf these patients suffer from osteolytic bone metastases at some time during the course of their disease (Elte et al. 1986). Hypercalcemia is a frequent complication in patients with extensive lesions in the skeleton. Osteolytic bone metastases cause severe morbidity and often incapacitate the patients.作者: 氣候 時間: 2025-3-23 02:45
https://doi.org/10.1007/978-3-642-83668-8bisphosphonates; bone; bone metastases; breast cancer; calcium; cancer; cancer research; carcinoma; metaboli作者: Merited 時間: 2025-3-23 08:44
978-3-642-83670-1Springer-Verlag Berlin Heidelberg 1989作者: Onerous 時間: 2025-3-23 13:28
Bisphosphonates and Tumor Osteolysis978-3-642-83668-8Series ISSN 0080-0015 Series E-ISSN 2197-6767 作者: Efflorescent 時間: 2025-3-23 15:10
0080-0015 Overview: 978-3-642-83670-1978-3-642-83668-8Series ISSN 0080-0015 Series E-ISSN 2197-6767 作者: 虛假 時間: 2025-3-23 19:54
,Die Hornochschen Aufgaben (134–155),f these patients suffer from osteolytic bone metastases at some time during the course of their disease (Elte et al. 1986). Hypercalcemia is a frequent complication in patients with extensive lesions in the skeleton. Osteolytic bone metastases cause severe morbidity and often incapacitate the patients.作者: 小步走路 時間: 2025-3-24 02:04
Recent Results in Cancer Researchhttp://image.papertrans.cn/b/image/188890.jpg作者: 偽善 時間: 2025-3-24 06:02
Treatment of Tumor Hypercalcemia with Clodronate,73), are under current clinical investigation to prove their effectivenes in hypercalcemia of malignancy. Etidronate, which is already used in the treatment of Paget’s disease (Holz et al. 1983) and heterotopic ossification (Garland et al. 1983), has been demonstrated to be beneficial also in tumor 作者: Counteract 時間: 2025-3-24 06:32 作者: Venules 時間: 2025-3-24 14:45 作者: Harrowing 時間: 2025-3-24 15:32 作者: COLIC 時間: 2025-3-24 22:13 作者: 嘲笑 時間: 2025-3-25 02:25
Treatment of Tumor-Induced Osteolysis by APD,ce of detectable bone metastases, especially in squamous cell carcinoma of the lung (“humoral hypercalcemia of cancer”) (Mundy et al. 1984). It is primarily due to increased bone resorption, and to a lesser degree in some tumors to increased tubular reabsorption of calcium, especially in squamous cell cancer. It is potentiated by dehydration.作者: 相容 時間: 2025-3-25 03:22
,Einführung in die Linsentheorie (27–46),tal aspects as well as clinical applications of these compounds. Literature is essentially limited to one reference, usually the original report. For two recent reviews, weighted somewhat differently and with more extensive references, see Fleisch (1983) and Francis and Martodam (1983).作者: 斷斷續(xù)續(xù) 時間: 2025-3-25 09:39 作者: Charitable 時間: 2025-3-25 13:54
Bisphosphonates: A New Class of Drugs in Diseases of Bone and Calcium Metabolism,tal aspects as well as clinical applications of these compounds. Literature is essentially limited to one reference, usually the original report. For two recent reviews, weighted somewhat differently and with more extensive references, see Fleisch (1983) and Francis and Martodam (1983).作者: 使高興 時間: 2025-3-25 17:39 作者: conifer 時間: 2025-3-25 23:21
Pathophysiological Aspects and Therapeutic Approaches of Tumoral Osteolysis and Hypercalcemia,ssociated with nausea, vomiting, dehydration, mental disturbance, confusion, and eventually coma. The appropriate management of tumor-mediated bone osteolysis and hypercalcemia requires an appreciation of the various factors implicated in bone remodeling and in Ca homeostasis (Mundy and Roodman 1987; Bonjour et al. 1987).作者: BRUNT 時間: 2025-3-26 02:47
,Fortsetzung der Linsentheorie (59–61),ssociated with nausea, vomiting, dehydration, mental disturbance, confusion, and eventually coma. The appropriate management of tumor-mediated bone osteolysis and hypercalcemia requires an appreciation of the various factors implicated in bone remodeling and in Ca homeostasis (Mundy and Roodman 1987; Bonjour et al. 1987).作者: 客觀 時間: 2025-3-26 07:07
Bisphosphonates: A New Class of Drugs in Diseases of Bone and Calcium Metabolism,etabolism. Three are on the market today, while others are under clinical or preclinical investigation. This chapter will cover chemical and experimental aspects as well as clinical applications of these compounds. Literature is essentially limited to one reference, usually the original report. For 作者: 古文字學(xué) 時間: 2025-3-26 08:45
Pathophysiological Aspects and Therapeutic Approaches of Tumoral Osteolysis and Hypercalcemia,ents of bone mineral (Rodman and Sherwood 1978; Mundy and Martin 1982). The clinical consequences of these disturbances can be dramatic on the degree of morbidity of cancer patients. Bone metastasis and osteolysis are a major source of pain, pathological fractures, and disability. Hypercalcemia is a作者: MUTED 時間: 2025-3-26 15:08 作者: 單調(diào)女 時間: 2025-3-26 17:39 作者: 敏捷 時間: 2025-3-27 00:56
Treatment of Tumor-Induced Osteolysis by APD,be lethal. It is primarily caused by malignant diseases (Fisken et al. 1980). Hypercalcemia of malignancy, also called “hypercalcemia of cancer,” “malignant hypercalcemia,” or “tumor-induced hypercalcemia,” is one of the most common metabolic complications of cancer (Mundy et al. 1984), and its cumu作者: Ptosis 時間: 2025-3-27 04:35
Clodronate Therapy of Metastatic Bone Disease in Patients with Prostatic Carcinoma,mission of some length, the final outcome is frequently progressive skeletal disease, despite orchiectomy and/or continuous hormone therapy. At this stage, the efficacy of cytotoxic drugs is limited (Posner et al. 1977) and radiation therapy is used only in persons with epidural spinal cord compress作者: 侵略 時間: 2025-3-27 06:42
Effect of Long-Term Bisphosphonate Treatment on Morbidity Due To Bone Metastases in Breast Cancer Pf these patients suffer from osteolytic bone metastases at some time during the course of their disease (Elte et al. 1986). Hypercalcemia is a frequent complication in patients with extensive lesions in the skeleton. Osteolytic bone metastases cause severe morbidity and often incapacitate the patien作者: 遠(yuǎn)地點 時間: 2025-3-27 12:48
9樓作者: arabesque 時間: 2025-3-27 17:17
10樓作者: 圓錐體 時間: 2025-3-27 20:04
10樓作者: 噱頭 時間: 2025-3-28 01:07
10樓作者: 捐助 時間: 2025-3-28 05:40
10樓
